In neurosurgery, few decisions carry as much weight as whether to operate. For patients with complex spinal conditions, the difference between intervention and observation can hinge on a fragile balance of risks, complications, recovery time, long-term function, many of which are difficult to predict with certainty.
Now, AI is beginning to reshape that calculation.
Instead of relying solely on published studies or generalized risk models, surgeons are increasingly turning to machine learning tools that promise something more precise: the ability to forecast outcomes based not just on national data, but on what has happened inside their own operating rooms.
For Kevin Huang, MD, a neurosurgeon at Boston-based Massachusetts General Hospital, that shift is both promising and incomplete.
“A lot of it comes down to the availability of data,” he said.
From generalized risk to personalized prediction
For decades, surgical decision-making has relied on models designed to be broadly applicable. Large studies conducted at high-volume centers would establish expected complication rates or outcomes, and those findings would then be applied across institutions. But those models have limits.
“They had to be generalizable, and they had to be predictive” Dr. Huang said.
AI offers a different approach. Instead of averaging outcomes across populations, machine learning models can analyze data at the level of an individual surgeon or hospital, looking at what has happened over the past six months or year, and identifying patterns that may not appear in broader datasets. The result, he said, is a more tailored form of risk prediction.
“They can be more accurate. They can be more personalized,” Dr. Huang said. “It’s a way in which personalized and tailor made medicine can really be brought to the surgical community.”
In theory, that could bring a new level of precision to surgical planning, allowing physicians to better anticipate complications and align treatment decisions with a patient’s specific risk profile.
Where the models fall short
But the promise of AI is tightly linked to its limitations. “These things are only as good as what you put into them,” Dr. Huang said. Machine learning models rely on structured data, variables that can be clearly defined and consistently recorded. In spine surgery, some of the most important factors do not fit neatly into those categories. How long a patient has been in pain, for example, can be a critical predictor of outcomes. But it is not always captured in a standardized way.
“Those may be some of the most important things,” he said.
As a result, even sophisticated models can miss elements that experienced surgeons weigh instinctively, creating a gap between what the data shows and what clinicians observe in practice.
The trust problem in high-stakes decisions
In neurosurgery, where the margin for error is narrow, adopting new technology requires more than technical performance. It requires trust.
For Dr. Huang, that trust depends on several factors: validation, transparency and a clear understanding of how a model was trained. “You want something that’s validated,” he said. “It’s important for a lot of these things to show their validation track record and understand what they’ve been validated on.”
Surgeons also want to know how predictions are generated, whether the system offers interpretable insights or functions as a “black box,” and whether it has been tested on patient populations similar to their own. Even then, adoption is not uniform.
Some surgeons are early adopters, willing to experiment with new tools and adapt their workflows. Others take a more cautious approach, waiting for stronger evidence before incorporating AI into clinical decision-making. “The field just isn’t quite there yet,” Dr. Huang said. “There is definitely an adoption curve.”
Why workflow matters more than hype
Beyond accuracy, another challenge lies in how these tools are developed. Too often, Dr. Huang said, AI systems are built in isolation, without input from the clinicians who will ultimately use them.
Developers create a product, and only then ask physicians to adopt it. That approach, he said, limits the technology’s real-world impact. “Having clinicians involved in the development of these things from the ground up is going to be critical,” he said.
The difference between a tool that improves outcomes and one that remains theoretical may come down to how well it fits into existing clinical workflows, and whether it addresses the practical realities of decision-making in the operating room.
An evolving role in a complex system
AI is already influencing multiple parts of healthcare, from diagnostics to administrative workflows. In neurosurgery, its role is still being defined. For now, Dr. Huang sees it as an evolving tool, one that holds significant promise but requires careful integration.
“There’s a great opportunity to enhance care at every stage,” he said.
But realizing that potential will require more than technological advancement. It will depend on better data, closer collaboration between clinicians and developers, and a deeper understanding of how these tools shape decisions in practice.
“The nitty gritty is where the rubber meets the road,” he said.
In a field where every decision carries lasting consequences, the question is not just whether AI can predict outcomes, but how much surgeons should rely on it when it matters most.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
